ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Ammonia → 4-(4-{(S)-1-[(S)-6-(2-Hydroxy-2-methyl-propyl)-2-oxo-6-phenyl-[1,3]oxazinan-3-yl]-ethyl}-phenyl)-piperidine-1-carboxylic acid methylamide

HRID 80976
印刷

反応式

HRID 80976 の反応式
CN.[C:3]([O-:6])([O-])=O.[K+].[K+].ClC(OC1C=C[C:16]([N+:19]([O-])=O)=CC=1)=O.[OH:22][C:23]([CH3:53])([CH3:52])[CH2:24][C@@:25]1([C:46]2[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=2)[O:30][C:29](=[O:31])[N:28]([C@H:32]([C:34]2[CH:39]=[CH:38][C:37]([CH:40]3[CH2:45][CH2:44][NH:43][CH2:42][CH2:41]3)=[CH:36][CH:35]=2)[CH3:33])[CH2:27][CH2:26]1.N>C(#N)C.CCN(CC)CC>[CH3:16][NH:19][C:3]([N:43]1[CH2:44][CH2:45][CH:40]([C:37]2[CH:38]=[CH:39][C:34]([C@@H:32]([N:28]3[CH2:27][CH2:26][C@:25]([CH2:24][C:23]([OH:22])([CH3:52])[CH3:53])([C:46]4[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=4)[O:30][C:29]3=[O:31])[CH3:33])=[CH:35][CH:36]=2)[CH2:41][CH2:42]1)=[O:6]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 222AmmoniaHCID 6329MethylamineHCID 11430Potassium CarbonateHCID 821294-Nitrophenyl chloroformateHCID 58109308(S)-6-(2-Hydroxy-2-methyl-propyl)-6-phenyl-3-[(S)-1-(4-piperidin-4-yl-phenyl)-ethyl]-[1,3]oxazinan-2-one

生成物 1

HCID 45101412
4-(4-{(S)-1-[(S)-6-(2-Hydroxy-2-methyl-propyl)-2-oxo-6-phenyl-[1,3]oxazinan-3-yl]-ethyl}-phenyl)-piperidine-1-carboxylic acid methylamide

試薬・触媒・溶媒 2

HCID 6342Acetonitrile溶媒HCID 8471Triethylamine溶媒

実験手順

MeNH2*HCl (27 mg) and K2CO3 (93 mg) were added to a solution of 4-nitrophenyl chloroformate (66 mg) in acetonitrile (2 mL) at room temperature. The resulting mixture was stirred at room temperature for 4 h, before (S)-6-(2-hydroxy-2-methyl-propyl)-6-phenyl-3-[(S)-1-(4-piperidin-4-yl-phenyl)-ethyl]-[1,3]oxazinan-2-one (110 mg) and NEt3 (53 μL) were added. The mixture was further stirred at room temperature overnight. Then, diluted aqueous ammonia solution was added and the resulting mixture was filtered. The filtrate was concentrated under reduced pressure and the residue was purified by HPLC on reversed phase (MeOH/H2O/NH3) to afford the title compound.

後処理

  1. additionwere added
  2. filtrationthe resulting mixture was filtered
  3. concentrationThe filtrate was concentrated under reduced pressure
  4. customthe residue was purified by HPLC on reversed phase (MeOH/H2O/NH3)

出典と根拠

ORDレコード
ord-52e9d8b331424c9fa1019b5ac0920e80
出典データセット
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08846668B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート